Blue Jet Healthcare FY26 results: revenue and profit decline

Revenue DeclineResults View source PDF Explain this filing

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.5%Reaction day

₹557.85

prior close

₹556.00

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.5%+2.1% vs market

Pharmaceuticals peers, median of 164sector-0.5%+3.0% vs sector

On the reaction day the stock moved 2.1 pts more than Nifty Smallcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.0

15m

+0.0

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.5+0.5+2.1-0.5+3.0

Next day

+3.3-0.2+3.5-0.7+4.0

+1.3-2.2+3.5-1.7+3.0

+3.2-0.7+3.9-1.3+4.5

+11.8+0.7+11.1-0.5+12.3

+8.8+1.0+7.8+0.2+8.5

+7.7+0.6+7.2+0.4+7.3

15d

+3.8-1.0+4.7-1.4+5.2

+5.4+2.0+3.4-1.7+7.1

+2.2+2.7-0.5+1.2+1.0

-3.4-0.5-2.9+0.6-3.9

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Audited FY26 standalone results filed. Revenue from operations fell to Rs 9,047 million from Rs 10,300 million (about 12 percent lower). Net profit dropped to Rs 2,471 million from Rs 3,052 million (about 19 percent decline). EPS came in at Rs 17.59 versus Rs 22.41. Auditor KKC and Associates gave a clean unqualified opinion with no going concern concerns. Board has proposed a final dividend subject to shareholder approval at the AGM.

Likely market impact

Revenue and profits fell year-on-year despite a clean audit. Results await shareholder adoption at the AGM.